WDHA Syndrome
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00131911) | National Cancer Institute (NCI) | 2005-06-01 |
| Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00075439) | National Cancer Institute (NCI) | 2003-12-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
Track WDHA Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.